Skip to main content

NASDAQ: AGRX Agile Therapeutics Anticipates Increased Growth In Q3 of 2022

Contact Details

Matt Riley - Head of Investor Relations & Corporate Communications

mriley@agiletherapeutics.com

Company Website

https://agiletherapeutics.com/

Recent Quotes

View More
Symbol Price Change (%)
AMZN  230.71
+1.46 (0.63%)
AAPL  267.39
-1.61 (-0.60%)
AMD  260.27
+2.26 (0.88%)
BAC  52.94
+0.07 (0.12%)
GOOG  271.47
+3.04 (1.13%)
META  747.86
-3.58 (-0.48%)
MSFT  537.00
-5.07 (-0.94%)
NVDA  208.57
+7.54 (3.75%)
ORCL  274.03
-6.80 (-2.42%)
TSLA  457.76
-2.79 (-0.61%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.